BridgeBio Pharma (BBIO) Asset Utilization Ratio (2019 - 2025)
Historic Asset Utilization Ratio for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to 0.34.
- BridgeBio Pharma's Asset Utilization Ratio rose 1406.9% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year increase of 1406.9%. This contributed to the annual value of 0.3 for FY2024, which is 180307.9% up from last year.
- According to the latest figures from Q3 2025, BridgeBio Pharma's Asset Utilization Ratio is 0.34, which was up 1406.9% from 0.24 recorded in Q2 2025.
- In the past 5 years, BridgeBio Pharma's Asset Utilization Ratio ranged from a high of 0.34 in Q3 2025 and a low of 0.0 during Q1 2021
- In the last 5 years, BridgeBio Pharma's Asset Utilization Ratio had a median value of 0.09 in 2022 and averaged 0.13.
- In the last 5 years, BridgeBio Pharma's Asset Utilization Ratio plummeted by 11041.03% in 2021 and then soared by 255292.22% in 2024.
- Over the past 5 years, BridgeBio Pharma's Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then skyrocketed by 883.85% to 0.11 in 2022, then plummeted by 86.52% to 0.02 in 2023, then surged by 1708.76% to 0.28 in 2024, then increased by 21.53% to 0.34 in 2025.
- Its Asset Utilization Ratio stands at 0.34 for Q3 2025, versus 0.24 for Q2 2025 and 0.14 for Q1 2025.